Vice President of Business & Corporate Development

About GenBio AI

GenBio AI is an AI for Science company on a mission to make biology fully computable. We are building AIDO (AI-Driven Digital Organism) to simulate living systems, decode biology holistically, and accelerate medical and scientific research. Our first step toward that mission is AIDO Cell, the first virtual cell world model that holistically simulates cell biology from molecules up to whole-cell behavior.

It enables researchers to run experiments virtually, predicting how cells respond to genetic changes, drugs and other interventions before going into the lab. It is supported by AIDO Foundry, an AI-builds-AI engineering framework for automating virtual cell development, and AIDO Lab, an interface to digitally run experiments and observe the results.

Together they form the foundation for a new paradigm in AI-driven drug discovery, bioengineering, and fundamental biomedical research. We seek a senior, highly strategic VP of Business & Corporate Development to define and lead GenBio AI's business development and strategic partnership efforts.

This is a high-ownership role for a leader who is technically credible, commercially seasoned, and comfortable setting direction rather than waiting for it. You will help shape GenBio AI's business model, build the relationships that turn our technology into durable scientific and commercial partnerships, and make the case to the market for what AIDO Cell makes possible.

You will work alongside the founders and executive team with the seniority and confidence to guide them, intellectually and operationally, and to take external work off their plates. You will see where GenBio AI's technology can create value, identify the gap between what it can do and what the market understands today, and close that gap through new connections, partnership structures, and proposed experiments.

The role requires strategic judgment, a strong scientific foundation, and the credibility to engage directly with senior leaders across the pharmaceutical and technology industries.